# Oral Cannabidiol Effect on Blood Pressure in Hypertensive Patients

> **NCT05346562** · PHASE1 · COMPLETED · sponsor: **University of Split, School of Medicine** · enrollment: 70 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Cannabidiol
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05346562
- **Lead sponsor:** University of Split, School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-08
- **Primary completion:** 2022-10-05
- **Final completion:** 2022-10-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-05-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05346562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05346562, "Oral Cannabidiol Effect on Blood Pressure in Hypertensive Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05346562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*